Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 11.81% |
| 4 | Communication Services | 10.53% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBFM
3276
Sunshine Biopharma
SBFM
$2.85M
| $83K | ﹤0.01% |
5,570
+161
| +3% | +$2.39K |
|
|
BRNS
3277
Barinthus Biotherapeutics
BRNS
$24.5M
| $82.9K | ﹤0.01% |
66,300
+30,000
| +83% | +$37.5K |
|
|
OKYO
3278
OKYO Pharma
OKYO
$79.2M
| $82.4K | ﹤0.01% |
+41,200
| New | +$105K |
|
3279
Ascent Solar Technologies
ASTI
$32.7M
| $82K | ﹤0.01% |
+41,818
| New | +$85K |
|
3280
Beamr Imaging
BMR
$19.7M
| $81.7K | ﹤0.01% |
+26,700
| New | +$81.6K |
|
|
STG
3281
Sunlands Technology
STG
$44.1M
| $80.8K | ﹤0.01% |
+10,098
| New | +$92.4K |
|
|
CARM
3282
DELISTED
Carisma Therapeutics
CARM
| $80.5K | ﹤0.01% |
293,686
-35,600
| -11% | -$11.8K |
|
|
HUHU
3283
HUHUTECH International Group
HUHU
$135M
| $80.2K | ﹤0.01% |
+15,600
| New | +$102K |
|
|
RVPH
3284
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $79.8K | ﹤0.01% |
+10,830
| New | +$92K |
|
3285
Oriental Culture Holding
OCG
$3.24M
| $78.6K | ﹤0.01% |
32
-6
| -16% | -$18K |
|
3286
Siebert Financial
SIEB
$78.1M
| $78.5K | ﹤0.01% |
26,900
+4,900
| +22% | +$16.9K |
|
3287
Drilling Tools International
DTI
$86.8M
| $78.5K | ﹤0.01% |
34,111
+24,071
| +240% | +$52.9K |
|
|
IMDX
3288
Insight Molecular Diagnostics
IMDX
$121M
| $78.4K | ﹤0.01% |
23,600
-2,500
| -10% | -$7.05K |
|
3289
PharmaCyte Biotech
PMCB
$5.9M
| $77.6K | ﹤0.01% |
80,000
+30,200
| +61% | +$30.1K |
|
3290
Lightwave Logic
LWLG
$1.12B
| $76.5K | ﹤0.01% |
20,607
-2,993
| -13% | -$7.72K |
|
|
TEAD
3291
Teads Holding Co
TEAD
$63.6M
| $76.2K | ﹤0.01% |
46,200
-49,800
| -52% | -$105K |
|
3292
Eve Holding
EVEX
$976M
| $76.2K | ﹤0.01% |
+20,000
| New | +$106K |
|
3293
Claros Mortgage Trust
CMTG
$268M
| $75.4K | ﹤0.01% |
+22,700
| New | +$76.4K |
|
|
KORE
3294
DELISTED
KORE Group Holdings
KORE
| $74.9K | ﹤0.01% |
30,941
+2,300
| +8% | +$5.49K |
|
|
ORGN
3295
DELISTED
Origin Materials
ORGN
| $73.6K | ﹤0.01% |
4,730
-12,237
| -72% | -$227K |
|
|
IPM
3296
Intelligent Protection Management Corp
IPM
$24.4M
| $73K | ﹤0.01% |
36,700
+2,600
| +8% | +$5.16K |
|
|
CASI
3297
DELISTED
CASI Pharmaceuticals
CASI
| $72.9K | ﹤0.01% |
43,900
+4,700
| +12% | +$8.38K |
|
|
GCL
3298
GCL Global Holdings
GCL
$61.8M
| $72.5K | ﹤0.01% |
+28,900
| New | +$97.3K |
|
|
ANEB
3299
DELISTED
Anebulo Pharmaceuticals
ANEB
| $71.3K | ﹤0.01% |
+28,500
| New | +$67.1K |
|
3300
Wah Fu Education Group
WAFU
$6.31M
| $71.2K | ﹤0.01% |
38,700
+16,800
| +77% | +$25.6K |
|
Similar funds
Jim Simons's Q3 2025 Portfolio in Review
As of Q3 2025, Jim Simons held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Alphabet (Google) Class C worth $419M.
- Jim Simons's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Jim Simons's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Jim Simons fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Jim Simons's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Jim Simons opened 516 new positions and closed 581 in Q3 2025.
- Jim Simons's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.